logo

Cytrx Corp. (CYTR)



Trade CYTR now with
  Date
  Headline
9/17/2020 8:11:19 AM CytRx Highlights Orphazyme's Receipt Of FDA Acceptance Of NDA For Arimoclomol For Niemann-Pick Disease Type C
8/13/2020 8:32:08 AM CytRx's Board Sends Letter To Stockholders To Expose Dissident Investor And His Misguided Campaign
7/21/2020 9:13:06 AM CytRx Highlights Orphazyme'Completion Of Rolling Submission Of NDA With FDA For Arimoclomol In NiemannPick Disease TypeC
6/1/2020 9:05:57 AM CytRx Highlights Orphazyme's Rolling Submission Of NDA With FDA For Arimoclomol In Niemann-Pick Disease Type-C
5/26/2020 9:09:03 AM CytRx Highlights Orphazyme's Receipt Of FDA Fast Track Designation For The Development Of Arimoclomol In ALS
6/19/2019 9:05:02 AM CytRx : Arimoclomol Licensee Orphazyme To Prepare Regulatory Submission In Europe For Niemann-Pick Disease Type C
5/15/2019 9:03:28 AM CytRx Q1 Revenue $9.34 Mln, 60.4% Increase From $5.94 Mln Prior Year
3/29/2019 9:03:08 AM CytRx 2018 Net Loss $12.7 Mln Or $0.41 Per Share
3/12/2019 9:03:46 AM CytRx :Centurion BioPharma's ACDx, Could Be First To Personalize Medicine For Albumin-Based Drug Delivery Systems
2/6/2019 9:07:12 AM CytRx Highlights Positive Phase 2/3 Trial Data From Arimoclomol Licensee Orphazyme A
12/21/2018 9:07:00 AM CytRx Announces Conclusion Of Pre-Clinical Phase For Its Albumin Binding Ultra High Potency LADR Drug Candidates
11/2/2018 9:05:59 AM CytRx Q3 Net Loss $3.3 Mln Or $0.10/Shr Vs Net Loss $5.1 Mln Or $0.19/Shr Prior Year
9/13/2018 9:09:34 AM CytRx Gets Milestone Payment Of $250,000 From Orphazyme
8/6/2018 8:34:38 AM CytRx Q2 Net Loss $3.0 Mln Or $0.10/Shr Vs Loss Of $14.4 Mln Or $0.60/Shr Last Year
6/28/2018 9:08:29 AM CytRx Highlights Aldoxorubicin Included In New NantCell Inc. Triple Negative Breast Cancer Clinical Trial
6/4/2018 9:12:25 AM CytRx Launches Centurion BioPharma To Advance LADR Albumin Binding Ultra-High Potency Oncology Drug Candidates
5/8/2018 8:35:17 AM CytRx Q1 Net Loss $4.1 Mln Or $0.15/Shr Vs Loss Of $11.0 Mln Or $0.60/Shr Last Year
5/3/2018 8:32:50 AM CytRx Corp. Names Eric Curtis President And COO